What's in a color? GSK wins injunction against Sandoz
This article was originally published in Scrip
GlaxoSmithKline has won the first round in a battle with Novartis's generics arm Sandoz over the color purple. A German court has handed down a preliminary injunction blocking Sandoz from selling its salmeterol/fluticasone product, AirFluSal Forspiro. The injunction is related to the fact that the colors of the AirFluSal Forspiro inhaler and GSK's Advair (salmeterol/fluticasone) are similar.